Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

The methods can provide high-quality cells for creating artificial hair follicles, blood vessels, and skin.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Recombinant keratin materials may better promote skin cell differentiation than natural keratin.

Stem cells are present in plucked hair follicles and can be maintained in culture.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Human induced pluripotent stem cells can be used to create cells that help grow hair.

Scientists created a long-lasting stem cell line from human hair that can turn into different skin and hair cell types.

Chemotherapy reduces splenic melanin in mice.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

Calancardin B may help reduce inflammation in immune cells.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Keratin 16 delays skin maturation and affects skin and hair development in mice.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Small changes in cell division and differentiation can activate blood progenitors.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Low fucosylation boosts stem cell growth in the eye.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.